Silvia Ragno

Chief Operating Officer, AZAFAROS B.V.
London, England, United Kingdom

Professional Overview

Silvia Ragno is an experienced Chief Operating Officer with a proven track record of driving operational excellence and strategic growth in the pharmaceutical industry. With expertise spanning drug development, external innovation, and business operations, she is adept at navigating complex industry challenges and spearheading transformative initiatives.

Experience Summary

Current Role

As the Chief Operating Officer at AZAFAROS B.V., Silvia is responsible for overseeing the company's day-to-day operations, leading cross-functional teams, and implementing strategies to enhance efficiency and profitability. In this role, she has played a pivotal role in streamlining processes, optimizing resource allocation, and fostering a culture of continuous improvement, positioning AZAFAROS for sustainable growth.

Career Progression

Prior to her current role, Silvia served as the Chief Operating Officer and Co-Founder at Stargazer Pharmaceuticals Inc., where she was instrumental in driving the company's strategic direction and operational excellence. During her tenure, she successfully navigated a Takeda secondment, leveraging her expertise to provide consultative COO services. Earlier in her career, Silvia held senior leadership positions at Takeda, Novartis, and Celldex Therapeutics, where she demonstrated her ability to spearhead complex projects, foster cross-functional collaboration, and deliver tangible business impact.

Academic Background

Silvia holds a strong academic foundation, with a postdoctoral scientist role at the Medical Research Council, where she honed her scientific expertise and research skills.

Areas of Expertise

• Pharmaceutical operations and business strategy

• Drug development and external innovation

• Driving operational efficiency and continuous improvement

• Cross-functional team leadership and collaboration

• Navigating complex industry challenges and regulatory environments

Professional Impact

Throughout her career, Silvia has consistently demonstrated her ability to drive measurable results and contribute to the success of the organizations she has been a part of. Her leadership and strategic vision have been instrumental in securing significant funding, optimizing resource allocation, and positioning companies for long-term growth and market competitiveness.

Conclusion

Silvia Ragno's extensive experience, strategic acumen, and unwavering commitment to excellence make her a valuable asset in the pharmaceutical industry. As the Chief Operating Officer at AZAFAROS B.V., she is poised to continue her track record of driving operational excellence, fostering innovation, and delivering sustainable growth for the company and its stakeholders.